For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 24-30, 2026
FDA and innovation FDA and CMS move on personalized gene therapies. The FDA released draft guidance that lets developers of…
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Search Posts
Blog
Beware of Asking FDA to Change Itself
Every five years, Congress must reauthorize a piece of legislation called the Prescription Drug User Fee Act (PDUFA), which gives the…
Op-Eds
Seeing Double Regulation
When asked to name the most controversial medical issues of the day, few people would pick eye care. However, in the past half-century, eye…
Citation
Weekend Reading: The True Story of Cosmetics
Citation
Do Cosmetics Really Cause Cancer?
Citation
The EWG Provides Food for (No) Thought
Study
The True Story of Cosmetics
Many environmental groups want to rid the world of synthetic chemicals. Now they are at war with your makeup.